Want a raise, pharma reps? Get into biotech sales instead
Tracy Staton
We regularly dig into compensation for top executives, but figures on the biopharma rank and file are harder to come by. So, if you've been waiting for those numbers, ...
Spinal Tap: Reviews Question Benefit Of Medtronic Spinal Product
esilverman
As the result of an unusual effort designed to bolster transparency in clinical trials, two independent analyses have found that a Medtronic product used as a bone ...
Royalty’s $8B offer wilts after Elan prevails in blocking bid
Ryan McBride
Royalty Pharma signed the death certificate on its $ 8 billion bid for biotech Elan, withdrawing its appeal of a decision from an Irish panel that blocked its ability ...
Omnio iPad app’s power to be unleashed via Physicians Interactive and docwise partnering
mia.burns
By Mia Burns
Physicians Interactive has entered a partnership with the social magazine docwise to release the power of customized digital content for medical professionals ...
Buzz on rare disease drugs puts ViroPharma in the M&A spotlight
John Carroll
ViroPharma's pipeline of drugs for rare diseases has reportedly stirred the interest of several pharma companies. And once word of the buyout buzz spread the Exton, ...
Takeda Diabetes Drugs Launched in U.S.
barbara.lempert
Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are ...
AstraZeneca picks Cambridge site as ground zero for R&D reinvention
John Carroll
Over the next three years the pharma company plans to build a $ 500 million complex on its new campus that will house its U.K. operations for biologics and small molecule ...
Mendor Announces CE Marking for its Diabetes Management Platform
barbara.lempert
ESPOO, Finland, June 18, 2013 /PRNewswire/ — Finnish diabetes technology company Mendor announces today the CE mark for its groundbreaking diabetes management ...
U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis
barbara.lempert
PARSIPPANY, N.J., June 17, 2013 /PRNewswire/ — Actavis, Inc. (NYSE: ACT) today announced that the United States Supreme Court has reversed the decision of the ...
Supreme Court Rules Drugmakers Can Be Sued For Pay-To-Delay Deals
esilverman
After years of anticipation and considerable debate, the US Supreme Court has ruled that drugmakers can face lawsuits over so-called pay-to-delay patent settlements, ...
Codman Neuro Obtains CE Mark for Enhanced Revive Se Thrombectomy Device
barbara.lempert
Self-Expanding Clot Removal Device for Ischemic Stroke
Features Newly Enhanced Navigation
PARIS, FRANCE– JUNE 13, 2013 – Codman Neuro*, part of DePuy Synthes ...
Opioid Dependence Survey Fact Sheet
mia.burns
Opioid Dependence U.S. General Population and Primary Care Doctor Survey Fact Sheet
Opioid dependence (OD; addiction) is more common than many people realize and can ...